Seattle Genetics, Inc. (NASDAQ:SGEN) is projected to declare fiscal fourth quarter financial results right after the stock markets official close on February 09, 2017. The stock added about 22.4 percent in price since last results when it was at $49.93 a share. Based on the most relevant past-periods data, there is an 60.71 percent probability for this firms share price to go down following next quarterly results. Earnings reaction history tells us that the equity price moved down 17 times out of last 28 reported quarters. It has beaten earnings-per-share estimates 66% of the time in its last 12 earnings reports. It fell short of earnings estimates on 4 occasions, and it has met expectations 0 time.

Heres how traders responded to SGEN earnings announcements over the past few quarters.

Seattle Genetics, Inc. (SGEN) Earnings Surprises & Reaction

Given its history, the average earnings announcement surprise was 2.19 percent over the past four quarters. Back on October 27, 2016, it posted earnings per-share earnings at $-0.23 which beat the consensus $-0.29 projection (positive surprise of20.69%. For the quarter, revenue came in at 106.32M versus consensus estimate of 101.74M. The stock gained 1.84 percent the session following the earnings reports were released, and on 7th day price change was 14.16 percent.

On July 26, 2016, it reported earnings at $-0.23 a share compared with the consensus estimate of $-0.33 per share (positive surprise of 30.3%). Revenue of 95.4M for that quarter was above the $94.13M analysts had expected. The stock climbed 9.62% the day following the earnings announcement, and on 7th day price change was 10.85%.

On April 28, 2016, it recorded $-0.15 a share in earnings which missed the consensus estimate of $-0.11 (negative surprise of -36.36%). Revenue for the quarter was $111.15M while analysts called for revenues to be $116.04M. The stock dropped -4.85% the day following the earnings data was made public, and on 7th day price change was -10.91%.

On February 9, 2016, it announced earnings per share at $-0.18 versus the consensus estimate of $-0.17 per share (negative surprise of -5.88%). That came on revenues of $93.48M for that period. Analysts had expected $88.28M in revenue.

Seattle Genetics, Inc. Earnings Estimates

As Q4 earnings announcement date approaches, Wall Street is expecting earnings per share of $-0.31. The analysts present consensus range is $-0.42-$-0.25 for EPS. The market consensus range for revenue is between $91.86M and $117.07M, with an average of $106.17M.

Seattle Genetics, Inc. (NASDAQ:SGEN) last ended at $61.11, sending the companys market cap near $8.65B. The consensus 12-month price target from analysts covering the stock is $58.79. The share price has declined -18.91% from its top level in 52 weeks and dropped 15.8% this year. It recently traded in a range of $59.57-$61.16 at a volume of 444485 shares. The recent trading ended with the price nearly 4.48 higher for the last 5 trading days, rebounding 134.86% from its 52-week low.

See the original post:
Seattle Genetics, Inc. (NASDAQ:SGEN) earnings reaction history - The Independent Republic